The launch in India of a new COVID-19 vaccine developed jointly by the Serum Institute of India and U.S.-based biotech firm Novavax is likely to be delayed to September, the Indian company’s boss said on Saturday.
On Saturday Poonawalla said the trials of Corovax had kicked off in India, but did not say why the vaccine launch was delayed.
